HIV Vaccines (X5) 2010
March 21 - 26, 2010(Ended)Fairmont Banff Springs
Banff, Canada
Banff, Canada
Traditionally, the Keystone Joint HIV
Symposia have integrated vaccines and pathogenesis to comprehensively
cover the field—from HIV’s fundamental biology to its interaction with
the human immune system and how to design a vaccine—and these Joint
Symposia have been convened every year. In addition to this Keystone
Joint Symposium, there are a couple of other well-established HIV
vaccine meetings in the year (CROI and the AIDS Vaccine Conference)
that follow a similar format and also often feature a similar line-up
of speakers. Since an HIV vaccine is proving to be a particularly
recalcitrant problem, a novel approach that facilitates a wider
cross-fertilization of ideas would be very valuable and would be
welcomed by the broader HIV vaccine research community. To that end,
the major development proposed for the 2010 Keystone HIV Vaccine
Symposium is to foster innovative ideas and new collaborations with
immunology and vaccinology as it pertains to other viral diseases.
Specifically, we propose that a new Joint Symposium of HIV Vaccines in
conjunction with Viral Immunity be convened. This Joint Symposium would
retain the valuable format that includes joint and separate sessions
covering general and specific principles.Venue
Address
405 Spray Avenue,
Banff,
Canada
Banff,
Canada
Prices *
520-845 US Dollar (Early registration date: January 21, 2010)
Abstract submission deadline
December 23, 2009
Organization
Concurrent events
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Effect Of Traditional Egyptian Herbal Medicine on Treatment of Hepatitis C virus (HCV)
- Medical Seminars for All in the Field
- Cochlear Implantation in Auditory Neuropathy
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Medical conferences—establishing awareness in medical fields
- Determine the prevalence of hypermetropia among young male and female
